Steris Agrees to Buy Xodus Medical for $2.1 Billion

what happened

Dow Jones Newswires reported that Steris has signed an agreement to purchase Xodus Medical, a specialty surgical-products company, for $2.1 billion. Steris said the transaction would broaden its portfolio with consumables used in surgical procedures. Xodus, which is based in Pennsylvania, develops and manufactures a variety of medical devices.

The company’s flagship Pink Pad is designed to hold patients in position during surgery when they are placed in Trendelenburg position, lying on their backs with their feet raised above their heads. Steris will acquire all of Xodus’s equity and expects to fund most of the purchase with debt. It also anticipates cash-tax benefits with a net present value of approximately $300 million.

The agreement provides for as much as $150 million in additional earnout payments if specified performance goals are met after closing in 2028. The companies estimate that Xodus Medical will post $245 million of 2026 revenue and roughly $135 million in adjusted earnings before interest and taxes. Completion is expected by Dec. 31, subject to regulatory clearances and other closing conditions. Steris plans to update its fiscal 2027 guidance after the deal closes.

why it matters

The acquisition would add surgical consumables to Steris’s portfolio, while debt-led financing makes the transaction relevant to the company’s capital structure. Regulatory approvals remain a closing requirement.

instruments